This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 598369
Submitted by lobbyist on: November 11, 2016 01:47:01 PM
Accepted by Registrar on: November 14, 2016 09:41:37 AM
Designated Filer Information
| Beauchamp, Norma |
| 2323 Yonge Street | |
|
Toronto, ON, M4P 2C9
|
416-485-9149 |
| Canada |
Organization Information
| Cystic Fibrosis Canada |
| Cystic Fibrosis Canada is a national charitable not-for-profit corporation established in 1960, and is one of the world's top three charitable organizations committed to finding a cure for cystic fibrosis (CF). As an internationally recognized leader in funding innovation and clinical care, we invest more in life-saving CF research and care than any other non-governmental agency in Canada. |
| 2323 Yonge Street | |
|
Toronto, ON, M4P 2C9
|
416-485-9149 |
| Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
| November 11, 2016 | |
| May 10, 2017 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Meeting with ministers related to the funding of a recently approved cystic fibrosis medication, lumicaftor/ivacaftor (brand name Orkambi).
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| MLA | Lake, Terry | Kamloops-North Thompson | November 11, 2016 |